查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950475

消化益生菌市場按產品形式、菌株類型、用途、最終用戶和分銷管道分類，全球預測（2026-2032年）

Gastrointestinal Function Regulating Probiotics Market by Product Form, Strain Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，胃腸功能調節益生菌市場價值將達到 14.2 億美元，到 2026 年將成長至 15.8 億美元，到 2032 年將達到 31.5 億美元，複合年成長率為 12.05%。

關鍵市場統計數據
基準年 2025 14.2億美元
預計年份：2026年 15.8億美元
預測年份 2032 31.5億美元
複合年成長率 (%) 12.05%

簡要概述影響胃腸道益生菌開發和商業化的菌株水平科學、配方要求和戰略重點

益生菌旨在調節胃腸道功能，它獨特地融合了臨床科學、消費者健康和食品技術創新。這些干預措施利用特定的微生物菌株和遞送平台來調節宿主微生物群，支持黏膜屏障功能，並影響腸-腦訊號通路。隨著對菌株特異性和製劑穩定性研究的深入，從研發和監管事務到市場行銷和供應鏈等相關人員必須通力合作，共同推進證據生成、產品差異化以及在不同人群中的實際應用。

菌株科學和製劑技術的進步以及消費者期望的變化將如何重塑臨床可信度和商業化路徑

由於菌株鑑定、個人化營養和監管要求的進步，腸道功能調節益生菌領域正在經歷變革。高解析度定序和代謝組學分析使研發人員能夠超越泛泛的菌株功效宣稱，獲得針對特異性機制的文獻資料，從而支持差異化市場定位。同時，消費者對腸道健康的關注點也從整體健康轉向具體的療效，例如減少抗生素相關性腹瀉或緩解大腸激躁症症狀，這迫使品牌採用更注重療效的通訊和臨床終點指標。

2025年後的關稅環境及其對原物料採購、供應鏈韌性和商業性定價策略的營運影響

2025年推出的關稅政策為跨境原料採購和成品分銷帶來了新的摩擦，促使製造商和品牌所有者重新評估其供應鏈結構。部分原料和包裝組件關稅的提高增加了部分進口商品的到岸成本，迫使採購部門優先考慮供應商多元化和盡可能選擇近岸外包。為此，許多相關人員加快了國內供應商的資格認證，並整合貨運以降低單位成本上升的風險。同時，物流合作夥伴擴大了保稅倉庫的使用，並最佳化了貨運整合，以維持利潤率。

將產品形態、治療用途、終端用戶需求、通路和菌株選擇與整合開發和上市策略聯繫起來的實用細分分析

詳細的市場區隔分析揭示了產品創新、臨床證據和商業性策略需要協調一致的領域。產品形態分為膠囊/錠劑、機能性食品/飲料、液體和粉末。在機能性食品/飲料類別中，飲料進一步細分為乳製品飲料和非乳製品飲料，食品則分為能量棒和點心。這些形態差異指南展示策略、穩定性測試和消費者定位，因為膠囊和粉劑具有便利性和定量服用的優點，而食品/飲料則便於融入日常飲食中。

美洲、歐洲、中東和非洲以及亞太地區的區域監管差異、消費者偏好和分銷管道結構如何影響產品設計和商業化選擇。

區域趨勢持續影響著全球範圍內的配方選擇、監管應對措施和商業化計劃。在美洲，消費者對腸道健康的高度關注以及涵蓋直銷模式（包括面向消費者的線上銷售和成熟的藥房網路）的成熟配銷通路，要求企業同時重視臨床驗證和電商最佳化。在美洲經營的品牌正透過整合臨床可信度和生活方式定位的行銷宣傳活動，推動成人和兒童市場的普及。

主要企業如何結合菌株獨家性、配方創新和全通路夥伴關係，在腸道健康產品領域建立永續的競爭優勢

該領域的主要企業正致力於以菌株獨家性、配方技術和分銷管道夥伴關係為核心的差異化策略。領先的創新者正投資於菌株特性研究和臨床項目，以證明其具有針對性的健康益處；而其他企業則透過穩定粉末、飲料添加劑或偏好的液體形式，在給藥方式和消費者體驗方面展開競爭。產品開發商與契約製造組織 (CMO) 之間的策略合作在滿足特殊生產需求方面發揮著至關重要的作用，尤其對於需要嚴格品管和低溫運輸相容性的多菌株混合物而言更是如此。

一項三管齊下的營運策略，旨在幫助領導者整合臨床證據、建立穩健的供應鏈以及針對特定管道的商業化策略，從而擴大其影響力。

為了實現永續價值，產業領導者應優先考慮三項平行措施：證據產生、配方和供應鏈韌性以及通路專屬商業化。首先，投資臨床項目，將以患者為中心的明確終點與菌株選擇相結合，盡可能優先進行隨機對照試驗，並利用真實世界數據補充試驗證據。其次，致力於最佳化配方，以提升穩定性、標靶遞送和消費者體驗，同時實現原料來源多元化，並選擇二級供應商以降低關稅和物流風險。第三，針對每個管道量身訂做銷售模式：數位管道需要以效果為基礎的行銷和訂閱式物流；藥局需要專門的標籤和教育；而整合到食品飲料產業則需要與品類合作夥伴共同開發。

採用透明的混合方法調查方法，整合臨床文獻、監管分析和相關人員訪談，以產生可操作的見解。

這些研究成果綜合了同儕審查的臨床文獻、監管指導文件、專利概況，並訪談了科學、商業和供應鏈等關鍵領域的相關人員。資料收集包括與製劑負責人、臨床研究人員、採購人員和通路經理進行深入討論，以驗證產品性能、生產限制和上市策略。分析方法結合了定性主題檢驗和法規結構的交叉綜合，以識別菌株選擇、製劑方法和商業化模式中可複製的模式。

融合臨床嚴謹性、配方完整性和商業性靈活性，以釋放腸道健康解決方案的治療價值並建立消費者長期信任。

隨著產業相關人員將科學嚴謹性與卓越營運相結合，腸道益生菌有望從一般健康產品轉型為以療效為導向的輔助治療產品。最有前景的途徑在於：明確菌株特性與可衡量的臨床終點之間的聯繫；開發能夠保持活性並滿足用戶偏好的配方；以及構建兼顧臨床可信度和消費者可及性的商業模式。那些實施整合策略，優先考慮標靶證據、永續採購和通路差異化的公司，將更有能力在實現商業性永續性的同時，為消費者帶來切實的健康益處。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 消化益生菌市場（依產品類型分類）

  • 膠囊和片劑
  • 機能性食品和飲料
    • 飲料
      • 乳製品飲料
      • 非乳製品飲料
    • 食物
      • 酒吧
      • 小吃
  • 液體
  • 粉末

9. 按菌株類型分類的消化系統益生菌市場

  • 雙歧桿菌
  • 乳酸菌
  • 多股

第10章 按應用分類的消化益生菌市場

  • 抗生素相關腹瀉
  • 便秘
  • 腹瀉
  • 一般消化系統健康
  • 發炎性腸道疾病
  • 大腸激躁症
  • 乳糖不耐症

第11章 依最終用戶分類的消化益生菌市場

  • 成人版
  • 老年人
  • 兒童

12. 消化益生菌市場依通路分類

  • 直銷
  • 線上零售
    • 品牌官方網站
    • 電子商務平台
    • 市場
  • 藥局
  • 專賣店
    • 健康食品店
    • 天然食品店
  • 超級市場和大賣場

13. 各地區的消化益生菌市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 消化益生菌市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國胃腸道益生菌市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國胃腸道益生菌市場

第17章：中國益生菌市場及其對消化功能調節的作用

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amway Corporation
  • Archer-Daniels-Midland Company
  • Bio-K Plus International Inc.
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • Church & Dwight Co., Inc.
  • Danone SA
  • Deerland Probiotics & Enzymes, Inc.
  • DSM-firmenich AG
  • i-Health, Inc.
  • International Flavors & Fragrances Inc.
  • Kerry Group plc
  • Lallemand Inc.
  • Lifeway Foods, Inc.
  • Lonza Group Ltd.
  • Meiji Holdings Co., Ltd.
  • Morinaga Milk Industry Co., Ltd.
  • Nestle SA
  • Novozymes A/S
  • Probi AB
  • Probiotics International Ltd.
  • Reckitt Benckiser Group plc
  • Tata Consumer Products Limited
  • UAS Laboratories, Inc.
  • Winclove Probiotics BV
  • Yakult Honsha Co., Ltd.
Product Code: MRR-4F7A6D4FD88A

The Gastrointestinal Function Regulating Probiotics Market was valued at USD 1.42 billion in 2025 and is projected to grow to USD 1.58 billion in 2026, with a CAGR of 12.05%, reaching USD 3.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.42 billion
Estimated Year [2026] USD 1.58 billion
Forecast Year [2032] USD 3.15 billion
CAGR (%) 12.05%

A concise orientation to strain-level science, formulation imperatives, and strategic priorities shaping gastrointestinal probiotic development and commercialization

Probiotics designed to regulate gastrointestinal function occupy a unique intersection of clinical science, consumer health, and food-technology innovation. These interventions harness defined microbial strains and delivery platforms to modulate host microbiota, support mucosal barrier function, and influence gut-brain signaling pathways. As research deepens on strain specificity and formulation stability, stakeholders from R&D and regulatory affairs to marketing and supply chain must align around evidence generation, product differentiation, and real world usability in diverse populations.

Understanding the mechanisms of action-adhesion to intestinal mucosa, competitive exclusion of pathogens, metabolite production such as short-chain fatty acids, and immunomodulation-enables more predictable translation from bench to shelf. Equally important are formulation choices that preserve viability and target delivery, along with rigorous safety characterization for vulnerable cohorts. Taken together, these elements define a strategic landscape where scientific rigor, consumer trust, and operational readiness determine which probiotic solutions will achieve meaningful clinical and commercial traction.

How advances in strain science, formulation technology, and evolving consumer expectations are reshaping clinical credibility and commercial pathways

The landscape for gastrointestinal function regulating probiotics is undergoing transformative shifts driven by advances in strain characterization, personalized nutrition, and regulatory expectations. High-resolution sequencing and metabolomic profiling are enabling developers to move beyond generic strain claims toward documented, mechanism-specific dossiers that support differentiated positioning. Concurrently, consumer interest in gut health is evolving from generic wellness aspirations to targeted outcomes such as relief from antibiotic associated diarrhea or symptom management in irritable bowel syndrome, prompting brands to adopt more outcome-driven messaging and clinical endpoints.

At the same time, formulation innovation is reshaping route-to-market possibilities. Encapsulation technologies, stabilized powders, and novel food matrices are enabling delivery in capsules and tablets, liquids, and increasingly in functional food and beverage formats that meet consumer preferences for convenience and clean label. Digital channels are accelerating product discovery and repeat purchase, while professional channels such as pharmacies and specialty health stores continue to influence clinical credibility. Together, these shifts require integrated strategies that combine robust clinical evidence, targeted communication, and supply chain agility to capture evolving demand.

The post-2025 tariff environment and its operational consequences for ingredient sourcing, supply chain resilience, and commercial pricing strategies

Tariff policies in 2025 introduced renewed friction for cross-border ingredient sourcing and finished goods movement, prompting manufacturers and brand owners to reassess supply chain configurations. Increased duties on select raw materials and packaging components have elevated landed costs for certain imports, driving procurement teams to prioritize supplier diversification and nearshoring where feasible. In response, many stakeholders accelerated qualification of domestic suppliers and consolidated shipments to mitigate per-unit cost increases, while logistics partners expanded use of bonded warehousing and optimized freight consolidation to preserve margin.

These tariff-related pressures also influenced product assortment decisions and pricing strategies. Some companies rebalanced their portfolios to emphasize locally sourced formulations or finished goods that are less sensitive to import duties, whereas others restructured commercial promotions to offset short-term cost inflation. Importantly, the tariff environment intensified dialogue between regulatory, procurement, and commercial teams to ensure compliance while maintaining market access. Effective post-2025 approaches blend contractual hedging, strategic inventory, and transparent consumer communication about quality and origin to sustain trust and protect margins.

Actionable segmentation insights linking product formats, therapeutic applications, end-user needs, distribution pathways, and strain choices into cohesive development and go-to-market strategies

A granular segmentation lens reveals where product innovation, clinical evidence, and commercial tactics must align. Product form spans Capsules & Tablets, Functional Food & Beverages, Liquid, and Powder; within Functional Food & Beverages, opportunities bifurcate into Beverages and Food, with Beverages further distinguished as Dairy Based Beverages and Non Dairy Beverages, and Food encompassing Bars and Snacks. These form distinctions guide shelf strategy, stability testing, and consumer positioning, as capsules and powders address convenience and measured dosing while foods and beverages enable integration into daily diets.

Application segmentation covers indications such as Antibiotic Associated Diarrhea, Constipation, Diarrhea, General Digestive Health, Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Lactose Intolerance, each demanding different clinical endpoints, safety considerations, and regulatory messaging. End users include Adult, Geriatric, and Pediatric populations, and each cohort imposes distinct formulation and labeling constraints; for example, pediatric products must account for taste masking and dosing simplicity, while geriatric offerings prioritize swallowability and comorbidity profiles. Distribution channels range from Direct Sales, Online Retail, Pharmacy, Specialty Stores, and Supermarket & Hypermarket; the Online Retail channel further divides into Brand Websites, E Commerce Platforms, and Marketplaces, while Specialty Stores include Health Food Stores and Natural Product Stores. Finally, strain type segmentation spans Bifidobacterium, Lactobacillus, and Multi Strain approaches, each with unique evidence expectations and manufacturing controls. Integrating these segmentation axes enables targeted product development pathways, regulatory strategies, and channel plans that match consumer needs with operational capabilities.

How regional regulatory nuances, consumer preferences, and channel structures in the Americas, EMEA, and Asia-Pacific inform product design and commercialization choices

Regional dynamics continue to shape formulation choices, regulatory navigation, and commercialization plans across the globe. In the Americas, consumer awareness of gut health is high and channel sophistication spans direct-to-consumer digital sales to well established pharmacy networks, prompting a dual focus on clinically substantiated claims and e-commerce optimization. Brands operating in the Americas benefit from integrated marketing campaigns that combine clinical credibility with lifestyle positioning to drive adoption across adult and pediatric segments.

Europe, Middle East & Africa present a more fragmented regulatory and reimbursement environment, with varying expectations for health claims and differing professional endorsement dynamics. This region rewards rigorous clinical documentation and close engagement with regulatory authorities, while localized flavor and product safety requirements influence formulation decisions. In the Asia-Pacific region, rapid urbanization and rising disposable incomes are driving demand for convenient functional foods and beverages, supported by strong retail ecosystems and growing online marketplaces. However, Asia-Pacific also requires careful navigation of local consumer preferences, ingredient sourcing norms, and regulatory pathways, necessitating flexible product design and culturally informed marketing.

How leading companies combine strain exclusivity, formulation innovation, and omnichannel partnerships to build durable competitive differentiation in gut health products

Key companies in this space pursue differentiated strategies centered on strain exclusivity, formulation technology, and channel partnerships. Leading innovators invest in strain characterization and clinical programs that substantiate targeted health outcomes, while others compete on delivery formats and consumer experience through stabilized powders, beverage integrations, or palatable liquid formats. Strategic collaborations between product developers and contract manufacturing organizations have become central to scaling specialized production demands, especially for multi strain blends that require rigorous quality control and cold chain considerations.

In parallel, commercial leaders are refining omnichannel distribution models that connect digital performance marketing with professional endorsement and pharmacy presence, enabling both rapid trial and sustained adherence. Companies that effectively integrate evidence generation with supply chain reliability and clear professional engagement are better positioned to influence formulary choices and consumer loyalty. Finally, nimble mid-sized companies often exploit niche indications or population segments to establish footholds that can later be expanded, underscoring the value of focused clinical programs and targeted channel deployment.

A three-track operational playbook for leaders to align clinical evidence, resilient supply chains, and channel-specific commercialization to scale impact

Industry leaders should prioritize three parallel tracks to capture durable value: evidence generation, formulation and supply chain resilience, and channel-specific commercialization. First, invest in clinical programs that align strain selection with clear, patient-centric endpoints; prioritize randomized, controlled studies where feasible and leverage real world data to complement trial evidence. Second, optimize formulations for stability, targeted delivery, and consumer experience, while diversifying ingredient sources and qualifying secondary suppliers to reduce tariff and logistics exposure. Third, tailor commercialization models by channel: digital channels require performance marketing and subscription logistics, pharmacies demand professional labeling and educational outreach, and food and beverage integrations necessitate co-creation with category partners.

Implementation should proceed through phased initiatives that allow rapid learning. Start with pilot clinical studies tied to a single form factor and indication, then extend successful formulations into adjacent formats and channels. Build strategic manufacturing partnerships that offer scalability and quality control, and invest in data systems that connect consumer feedback, adherence metrics, and adverse event monitoring. By executing these integrated actions, leaders can turn scientific differentiation into sustained market preference and operational resilience.

A transparent mixed-methods research approach integrating clinical literature, regulatory analysis, and stakeholder interviews to produce actionable insights

The research behind these insights synthesizes peer-reviewed clinical literature, regulatory guidance documents, patent landscapes, and primary stakeholder interviews across scientific, commercial, and supply chain functions. Data collection included in-depth discussions with formulators, clinical investigators, procurement leads, and channel managers to triangulate product performance, manufacturing constraints, and go-to-market practices. Analytical methods combined qualitative thematic analysis with cross-cutting synthesis of regulatory frameworks to identify reproducible patterns in strain selection, formulation approaches, and commercialization models.

Quality assurance included independent verification of clinical study designs and endpoints, review of stability data where available, and confirmation of distribution channel behaviors through retailer and platform observations. The methodology emphasizes transparency, replicability, and pragmatic relevance, enabling decision-makers to translate the findings into prioritized action items and further investigative questions tailored to specific organizational needs.

Converging clinical rigor, formulation integrity, and commercial agility to unlock therapeutic value and long-term consumer trust in gut health solutions

Gastrointestinal function regulating probiotics are poised to move from general wellness products to outcome-driven therapeutic adjuncts when industry actors align scientific rigor with operational excellence. The most promising pathways involve clear linkage of strain identity to measurable clinical endpoints, formulations that preserve viability and meet user preferences, and commercial models that bridge clinical credibility with consumer accessibility. Firms that execute integrated strategies-prioritizing targeted evidence, resilient sourcing, and channel differentiation-will be best positioned to deliver meaningful health benefits while achieving commercial sustainability.

Moving forward, continued investment in high-quality clinical trials, pragmatic real world evidence collection, and flexible manufacturing partnerships will be essential. By focusing on these priorities, stakeholders can reduce translational risk, increase consumer trust, and unlock new applications for probiotics in managing defined gastrointestinal conditions and supporting everyday digestive health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Function Regulating Probiotics Market, by Product Form

  • 8.1. Capsules & Tablets
  • 8.2. Functional Food & Beverages
    • 8.2.1. Beverages
      • 8.2.1.1. Dairy Based Beverages
      • 8.2.1.2. Non Dairy Beverages
    • 8.2.2. Food
      • 8.2.2.1. Bars
      • 8.2.2.2. Snacks
  • 8.3. Liquid
  • 8.4. Powder

9. Gastrointestinal Function Regulating Probiotics Market, by Strain Type

  • 9.1. Bifidobacterium
  • 9.2. Lactobacillus
  • 9.3. Multi Strain

10. Gastrointestinal Function Regulating Probiotics Market, by Application

  • 10.1. Antibiotic Associated Diarrhea
  • 10.2. Constipation
  • 10.3. Diarrhea
  • 10.4. General Digestive Health
  • 10.5. Inflammatory Bowel Disease
  • 10.6. Irritable Bowel Syndrome
  • 10.7. Lactose Intolerance

11. Gastrointestinal Function Regulating Probiotics Market, by End User

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Gastrointestinal Function Regulating Probiotics Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Online Retail
    • 12.2.1. Brand Websites
    • 12.2.2. E Commerce Platforms
    • 12.2.3. Marketplaces
  • 12.3. Pharmacy
  • 12.4. Specialty Stores
    • 12.4.1. Health Food Stores
    • 12.4.2. Natural Product Stores
  • 12.5. Supermarket & Hypermarket

13. Gastrointestinal Function Regulating Probiotics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Function Regulating Probiotics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Function Regulating Probiotics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastrointestinal Function Regulating Probiotics Market

17. China Gastrointestinal Function Regulating Probiotics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amway Corporation
  • 18.6. Archer-Daniels-Midland Company
  • 18.7. Bio-K Plus International Inc.
  • 18.8. BioGaia AB
  • 18.9. Chr. Hansen Holding A/S
  • 18.10. Church & Dwight Co., Inc.
  • 18.11. Danone S.A.
  • 18.12. Deerland Probiotics & Enzymes, Inc.
  • 18.13. DSM-firmenich AG
  • 18.14. i-Health, Inc.
  • 18.15. International Flavors & Fragrances Inc.
  • 18.16. Kerry Group plc
  • 18.17. Lallemand Inc.
  • 18.18. Lifeway Foods, Inc.
  • 18.19. Lonza Group Ltd.
  • 18.20. Meiji Holdings Co., Ltd.
  • 18.21. Morinaga Milk Industry Co., Ltd.
  • 18.22. Nestle S.A.
  • 18.23. Novozymes A/S
  • 18.24. Probi AB
  • 18.25. Probiotics International Ltd.
  • 18.26. Reckitt Benckiser Group plc
  • 18.27. Tata Consumer Products Limited
  • 18.28. UAS Laboratories, Inc.
  • 18.29. Winclove Probiotics B.V.
  • 18.30. Yakult Honsha Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CAPSULES & TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CAPSULES & TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DAIRY BASED BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DAIRY BASED BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DAIRY BASED BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NON DAIRY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NON DAIRY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NON DAIRY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SNACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SNACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SNACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MULTI STRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MULTI STRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MULTI STRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ANTIBIOTIC ASSOCIATED DIARRHEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ANTIBIOTIC ASSOCIATED DIARRHEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ANTIBIOTIC ASSOCIATED DIARRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CONSTIPATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CONSTIPATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIARRHEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIARRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GENERAL DIGESTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GENERAL DIGESTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GENERAL DIGESTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOSE INTOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOSE INTOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOSE INTOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NATURAL PRODUCT STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NATURAL PRODUCT STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NATURAL PRODUCT STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 214. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 215. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 217. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 245. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 247. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 248. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 250. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 255. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 256. NATO GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 258. NATO GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL F